By Assoc. Prof. Dr. Mehmet Sorar | Published: 01.02.2025
Parkinson Plus Treatment in Ankara: Information About the Treatment Process
Parkinson Plus care starts with an assessment and diagnosis, then continues with medicines and therapies for symptoms, delivered by a team. No treatment is known to stop these conditions, so care is aimed at symptoms. This page explains the steps and what to ask when judging a care service, and it names no centre.
What happens during assessment?
Assessment is a careful review of the symptoms and how they have developed, because no single test makes the diagnosis. The NHS says a neurologist diagnoses multiple system atrophy (MSA) from the symptoms, how long they have lasted and how quickly they worsen, and that early symptoms can look like Parkinson's disease. For progressive supranuclear palsy (PSP), the diagnosis rests on the pattern of symptoms after other conditions, such as Parkinson's disease, have been ruled out.
An assessment can include:
- a detailed review of symptoms and medical history
- brain scans when needed (MRI, CT or SPECT for dementia with Lewy bodies, DLB) and blood tests to rule out other causes
- tests of mental ability, memory or language
Doctors also work from formal diagnostic criteria for each condition. They are explained on Parkinson Plus treatment doctor, how to choose and what to ask.
What does a treatment plan aim for?
The plan aims to reduce symptoms and protect everyday function, not to stop the disease. Lamb and colleagues, in a review of PSP and corticobasal degeneration (CBD), say there is no disease-modifying treatment (one that changes the course of the disease), no approved drug reliably controls symptoms, and most recommendations rest on other conditions, case series or expert opinion. Levodopa, the main Parkinson's medicine, may help slowness and stiffness, but the benefit is often small and short-lived. A poor response to it is part of the diagnostic picture in both conditions.
The NHS pages outline the steps by condition:
- MSA: medicines for dizziness and sleep problems, speech therapy for swallowing and communication, physiotherapy and occupational therapy
- PSP: medicines for stiffness, physiotherapy, speech and language therapy, occupational therapy, botulinum toxin (an injected muscle-relaxing medicine) or special glasses for eye problems, and a feeding tube if swallowing becomes severely difficult
- DLB: medicines for hallucinations, confusion, drowsiness, movement and sleep problems, which the NHS says may keep symptoms under control for several years
Which option fits which symptom is covered on Parkinson Plus syndrome, a map for the journey.
Who is on the care team?
Care is the work of a team rather than a single doctor. For PSP and CBD, Lamb and colleagues list neurology, physiotherapy, occupational therapy, speech and language therapy, dietetics (nutrition advice), ophthalmology (eye care), psychology and palliative care. Palliative care focuses on comfort and support and is given alongside other treatment.
Not everyone needs every member at once. The team widens as symptoms appear, and speech therapy can serve both swallowing and communication problems, according to the NHS. Asking the doctor which referrals are planned is usually enough; you do not have to assemble the team alone.
Where do surgery and deep brain stimulation fit?
Deep brain stimulation (DBS, electrodes placed in the brain that deliver electrical pulses) is not an established part of care for these conditions. Artusi and colleagues reviewed it in atypical parkinsonism and found 25 studies covering 66 people, including 31 with PSP, 22 with MSA and 12 with DLB. Only three studies were randomised controlled trials, and most had a high risk of bias. The authors conclude that current evidence does not support DBS here. It is established for advanced Parkinson's disease, but because of expert consensus and a lack of trials it is not recommended in atypical parkinsonism.
The review noted three signals: frequent thinking and behaviour problems in people with MSA given stimulation of the subthalamic nucleus, low complication rates in studies of the nucleus basalis of Meynert in DLB, and a possible good response of dystonia (involuntary muscle contractions) in PSP to stimulation of the globus pallidus. The abstract gives no numbers for each condition.
Wen and colleagues reviewed PSP alone: 14 studies and 39 people, 35 of whom had stimulation of the pedunculopontine nucleus. Most people had a lower movement score with stimulation on, but the differences were not statistically significant (9 people followed under 12 months, p = 0.051; 9 people followed 12 months or more, p = 0.151). A gain of more than 30% was reached in none of 5 people with one-sided stimulation and in 2 of 14 with two-sided stimulation, according to the paper's table, which has an inconsistency in its counts. Side effects included bleeding during surgery in two people, temporary apathy, tingling, double vision and slurred speech. The authors conclude the evidence does not show that DBS is effective in PSP, though some people may benefit, and they note few studies, many case reports, inconsistent settings and selection and publication bias.
DBS for Parkinson's disease itself is described on Deep brain stimulation (DBS) in Parkinson's disease. The position of transcranial magnetic stimulation (TMS) is on Parkinson Plus and TMS.
What can you look for when judging a care service in Ankara?
This guide gives no names or rankings. You can check these points by asking:
- Does the doctor explain how Parkinson's disease and other causes were ruled out, and how certain the diagnosis is?
- Is the plan built around the condition and the symptoms that appear?
- Is there access or referral to physiotherapy, speech and language therapy, occupational therapy, dietetics and eye care?
- Is palliative care mentioned as part of the team?
- Does the service avoid promising a treatment that stops the disease, and describe the evidence for options such as TMS and DBS openly?
These points do not say whether a service is good or poor; they show what to ask. The wider picture of the group is on Overview of Parkinson Plus disease.
Which changes should be reported without waiting for the next visit?
Fainting, a fall that causes injury, choking or repeated coughing when eating or drinking, and any sudden change from the person's usual pattern should be reported without waiting. The NHS lists dizziness or fainting among MSA symptoms, and says a feeding tube may be needed when swallowing in PSP becomes severely difficult. The care team can then say whether the change belongs to the condition. For choking that does not clear, severe breathlessness or a serious injury, call emergency services first.
Sources
- NHS: Multiple system atrophy (MSA)
- NHS: Progressive supranuclear palsy (PSP)
- NHS: Dementia with Lewy bodies
- Lamb and colleagues, Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options (2016)
- Artusi and colleagues, Deep brain stimulation for atypical parkinsonism: A systematic review on efficacy and safety (2022)
- Wen and colleagues, The Application of Deep Brain Stimulation for Progressive Supranuclear Palsy: A Systematic Review (2022)
This article is for general information and does not replace medical diagnosis or treatment. Please consult your physician for advice about your own condition.
Assoc. Prof. Dr. Mehmet Sorar
Neurosurgeon in Ankara. Graduated from Gazi University Faculty of Medicine in 1997, specialist since 2004, associate professor since 2019. Full CV
Related treatment page: Parkinson Plus